The H1N1 subtype of influenza A virus has caused substantial morbidity and mortality in humans, first documented in the global pandemic of 1918 and continuing to the present day. Despite this disease burden, the evolutionary history of the A/H1N1 virus is not well understood, particularly whether there is a virological basis for several notable epidemics of unusual severity in the 1940s and 1950s. Using a data set of 71 representative complete genome sequences sampled between 1918 and 2006, we show that segmental reassortment has played an important role in the genomic evolution of A/H1N1 since 1918. Specifically, we demonstrate that an A/H1N1 isolate from the 1947 epidemic acquired novel PB2 and HA genes through intra-subtype reassortment, which may explain the abrupt antigenic evolution of this virus. Similarly, the 1951 influenza epidemic may also have been associated with reassortant A/H1N1 viruses. Intra-subtype reassortment therefore appears to be a more important process in the evolution and epidemiology of H1N1 influenza A virus than previously realized.
References
[1]
Johnson NP, Mueller J (2002) Updating the accounts: global mortality of the 1918–1920 “Spanish” influenza pandemic. Bull Hist Med 56: 105–115.
[2]
Taubenberger JK, Morens DM (2006) 1918 influenza: the mother of all pandemics. Emerg Infect Dis 12: 15–22.
[3]
Kilbourne ED (2006) Influenza pandemics of the 20th century. Emerg Infect Dis 12: 9–14.
[4]
Logan WP, MacKay DG (1951) Development of influenza epidemics. Lancet 260: 284–285.
[5]
Taubenberger JK, Reid AH, Janczewski TA, Fanning TG (2001) Integrating historical, clinical and molecular data in order to explain the origin and virulence of the 1918 Spanish influenza virus. Phil Trans R Soc Lond B 356: 1829–1839.
[6]
Collins SD, Lehmann J (1951) Trends and epidemics of influenza and pneumonia, 1918–1951. Public Health Reports 66: 1487–1507.
[7]
Rasmussen AF, Stokes J, Smadel JE (1948) The army experience with influenza, 1946–1947. Am J Epidemiol 47: 142–149.
[8]
Sartwell PE, Long AP (1948) The army experience with influenza, 1946–1947. Am J Epidemiol 47: 135–141.
[9]
Salk JE, Suriano PC (1949) Importance of antigenic composition of influenza virus vaccine in protecting against the natural disease. Am J Public Health 39: 345–355.
[10]
Kilbourne ED, Smith C, Brett I, Pokorny BA, Johansson B, et al. (2002) The total influenza vaccine failure of 1947 revisited: major intrasubtypic antigenic change can explain failure of vaccine in a post-World War II epidemic. Proc Natl Acad Sci USA 99: 10748–10752.
[11]
Isaacs A, Gledhill AW, Andrewes CH (1952) Influenza A viruses: laboratory studies, with special reference to European outbreak of 1950-1. Bull World Hlth Org 6: 287–315.
[12]
Viboud C, Tam T, Fleming D, Miller M, Simonsen L (2006) 1951 influenza epidemic, England and Wales, Canada, and the United States. Emerg Infect Dis 12: 661–668.
[13]
Scholtissek C, Rohde W, Von Hoyningen V, Rott R (1978) On the origin of the human influenza virus subtype H2N2 and H3N2. Virology 87: 13–20.
[14]
Weekly Epidemiological Record (1977) Influenza. 52: 401.
[15]
Weekly Epidemiological Record (1978) Influenza. 53: 22–23.
[16]
Kendal AP, Noble GR, Skehel JJ, Dowdle WR (1978) Antigenic similarity of influenza A (H1N1) viruses from epidemics in 1977–1978 to “Scandinavian” strains isolated in epidemics of 1950–1951. Virology 89: 632–636.
[17]
Scholtissek C, von Hoyningen V, Rott R (1978) Genetic relatedness between the new 1977 epidemic strains (H1N1) of influenza and human influenza strains isolated between 1947 and 1957 (H1N1). Virology 89: 613–617.
[18]
Cox NJ, Black RA, Kendal AP (1989) Pathways of evolution of influenza A (H1N1) viruses from 1977 to 1986 as determined by oligonucleotide mapping and sequencing studies. J Gen Virol 70: 299–313.
[19]
Simonsen L, Clarke ML, Schonberger LB, Arden NH, Cox NJ, et al. (1998) Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Disease 178: 53–60.
[20]
Centers for Disease Control and Prevention (2007) Update: influenza activity – United States and worldwide, 2006–2007 and composition of the 2007–2008 influenza vaccine. MMWR 56: 789–794.
[21]
Kawaoka Y, Krauss S, Webster RG (1989) Avian-to-human transmission of the PB1 gene of influenza A viruses in 1957 and 1968 pandemics. J Virol 63: 4603–4608.
[22]
Young JF, Palese P (1979) Evolution of human influenza A viruses in nature: recombination contributes to genetic variation of H1N1 isolates. Proc Natl Acad Sci USA 76: 6547–6551.
[23]
Xu X, Rocha EP, Regenery HL, Kendal AP, Cox NJ (1993) Genetic and antigenic analyses of influenza A (H1N1) viruses, 1986–1991. Virus Res 28: 37–55.
[24]
Guo Y, Xu X, Cox NJ (1992) Human influenza A (H1N2) viruses isolated from China. J Gen Virol 73: 383–388.
[25]
Holmes EC, Ghedin E, Miller N, Taylor J, Bao Y, et al. (2005) Whole-genome analysis of human influenza A virus reveals multiple persistent lineages and reassortment among recent H3N2 viruses. PLoS Biol 3: e300.
[26]
Hay AJ, Gregory V, Douglas AR, Lin YP (2001) The evolution of human influenza viruses. Phil Trans R Soc Lond B 356: 1861–1870.
[27]
Centers for Disease Control and Prevention (2007) Update: influenza activity – United States and worldwide, 2006–2007 and composition of the 2007–2008 influenza vaccine. MMWR 56: 789–794.
[28]
Wolf Y, Viboud C, Holmes EC, Koonin EV, Lipman DJ (2006) Long intervals of stasis punctuated by bursts of positive selection in the seasonal evolution of influenza A virus. Biol Direct 1: 34.
[29]
Ferguson NM, Galvani AP, Bush RM (2003) Ecological and immunological determinants of influenza evolution. Nature 422: 428–433.
[30]
Nakajima K, Desselberger U, Palese P (1978) Recent human influenza A (H1N1) viruses are closely related genetically to isolates isolated in 1950. Nature 274: 334–339.
[31]
Oxford JS (2000) Influenza A pandemics of the 20th century with special reference to 1918: virology, pathology and epidemiology. Rev Med Virology 10: 119–133.
[32]
Nakajima S, Nishikawa F, Nakajima K (2002) Comparison of the evolution of recent and late phase of old influenza A (H1N1) viruses. Microbiol Immunol 44: 841–847.
[33]
Nelson MI, Simonsen L, Viboud C, Miller MA, Taylor J, et al. (2006) Stochastic processes are key determinants of short-term evolution in influenza A virus. PLoS Pathog 2: e125.
[34]
Bush RM, Fitch WM, Bender CA, Cox NJ (1999) Positive selection on the H3 hemagglutinin gene of human influenza virus A. Mol Biol Evol 16: 1457–1465.
[35]
Cox NJ, Subbarao K (2000) Global epidemiology of influenza: past and present. Annu Rev Med 51: 407–421.
[36]
Viboud C, Tam T, Fleming D, Handel A, Miller M, Simonsen L (2006) Transmissibility and mortality impact of epidemic and pandemic influenza, with emphasis on the unusually deadly 1951 epidemic. Vaccine 24: 6701–6707.
[37]
Ghedin E, Sengamalay NA, Shumway M, Zaborsky J, Feldblyum T, et al. (2005) Large-scale sequencing of human influenza reveals the dynamic nature of viral genome evolution. Nature 437: 1162–1166.
[38]
Swofford DL (2003) PAUP*: Phylogenetic analysis using parsimony (*and other methods) version 4.0 [computer program]. Sunderland, Massachusetts: Sinauer Associates.
[39]
Posada D, Crandall KA (1998) MODELTEST: testing the model of DNA substitution. Bioinformatics 14: 817–818.
[40]
Maddison DR, Maddison WP (2000) MacClade. Analysis of Phylogeny and Character Evolution, version 4.0 [computer program]. Sunderland, Massachusetts: Sinauer Associates.
